Brooklyn, NY, United States of America

Joan A Windsor



 

Average Co-Inventor Count = 10.3

ph-index = 4

Forward Citations = 193(Granted Patents)


Location History:

  • Brooklyn, NY (US) (2009 - 2012)
  • Princeton, NJ (US) (2012)

Company Filing History:


Years Active: 2009-2012

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Joan A. Windsor: Innovator in Antibody Research

Introduction

Joan A. Windsor is a prominent inventor based in Brooklyn, NY (US), known for her significant contributions to the field of antibody research. With a total of 7 patents to her name, she has made remarkable strides in developing high-affinity human antibodies that target specific receptors.

Latest Patents

Among her latest patents, one notable invention is the development of high-affinity human antibodies to the human IL-4 receptor. This isolated human antibody or antigen-binding fragment binds to the human interleukin-4 receptor alpha (hIL-4Rα) with an affinity constant (K) of less than 200 pM, as measured by surface plasmon resonance. Another significant patent involves high-affinity human antibodies to the human IL-18 receptor. This invention includes an isolated antibody or antibody fragment that binds to the human interleukin-18 receptor alpha (hIL-18Rα), featuring specific light chain and heavy chain variable regions.

Career Highlights

Joan A. Windsor is currently associated with Regeneron Pharmaceuticals, Inc., where she continues to advance her research in antibody development. Her work has been instrumental in enhancing therapeutic options for various diseases.

Collaborations

Throughout her career, Joan has collaborated with notable colleagues, including Sean Stevens and Joel H. Martin, contributing to a dynamic research environment that fosters innovation.

Conclusion

Joan A. Windsor's contributions to antibody research exemplify her dedication to scientific advancement. Her innovative patents and collaborations highlight her role as a leading inventor in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…